Complement as a target in COVID-19?

There is an urgent need to develop effective therapies for COVID-19. Here, we urge immunologists and clinicians to consider the potential of targeting the complement system in these patients.

Detalles Bibliográficos
Autores principales: Risitano, Antonio M., Mastellos, Dimitrios C., Huber-Lang, Markus, Yancopoulou, Despina, Garlanda, Cecilia, Ciceri, Fabio, Lambris, John D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187144/
https://www.ncbi.nlm.nih.gov/pubmed/32327719
http://dx.doi.org/10.1038/s41577-020-0320-7
_version_ 1783527111065075712
author Risitano, Antonio M.
Mastellos, Dimitrios C.
Huber-Lang, Markus
Yancopoulou, Despina
Garlanda, Cecilia
Ciceri, Fabio
Lambris, John D.
author_facet Risitano, Antonio M.
Mastellos, Dimitrios C.
Huber-Lang, Markus
Yancopoulou, Despina
Garlanda, Cecilia
Ciceri, Fabio
Lambris, John D.
author_sort Risitano, Antonio M.
collection PubMed
description There is an urgent need to develop effective therapies for COVID-19. Here, we urge immunologists and clinicians to consider the potential of targeting the complement system in these patients.
format Online
Article
Text
id pubmed-7187144
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-71871442020-04-28 Complement as a target in COVID-19? Risitano, Antonio M. Mastellos, Dimitrios C. Huber-Lang, Markus Yancopoulou, Despina Garlanda, Cecilia Ciceri, Fabio Lambris, John D. Nat Rev Immunol Comment There is an urgent need to develop effective therapies for COVID-19. Here, we urge immunologists and clinicians to consider the potential of targeting the complement system in these patients. Nature Publishing Group UK 2020-04-23 2020 /pmc/articles/PMC7187144/ /pubmed/32327719 http://dx.doi.org/10.1038/s41577-020-0320-7 Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Comment
Risitano, Antonio M.
Mastellos, Dimitrios C.
Huber-Lang, Markus
Yancopoulou, Despina
Garlanda, Cecilia
Ciceri, Fabio
Lambris, John D.
Complement as a target in COVID-19?
title Complement as a target in COVID-19?
title_full Complement as a target in COVID-19?
title_fullStr Complement as a target in COVID-19?
title_full_unstemmed Complement as a target in COVID-19?
title_short Complement as a target in COVID-19?
title_sort complement as a target in covid-19?
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187144/
https://www.ncbi.nlm.nih.gov/pubmed/32327719
http://dx.doi.org/10.1038/s41577-020-0320-7
work_keys_str_mv AT risitanoantoniom complementasatargetincovid19
AT mastellosdimitriosc complementasatargetincovid19
AT huberlangmarkus complementasatargetincovid19
AT yancopouloudespina complementasatargetincovid19
AT garlandacecilia complementasatargetincovid19
AT cicerifabio complementasatargetincovid19
AT lambrisjohnd complementasatargetincovid19

Ejemplares similares